Valproic acid for nonaffective aggression in... [J Nerv Ment Dis. 1992] - PubMed

loading

Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. [J Clin Psychiatry. 1991]
Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
Ratey J, Sovner R, Parks A, Rogentine K. J Clin Psychiatry. 1991 Apr; 52(4):159-62.
Lithium carbonate for aggression in mentally retarded persons. [Compr Psychiatry. 1989]
Lithium carbonate for aggression in mentally retarded persons.
Spreat S, Behar D, Reneski B, Miazzo P. Compr Psychiatry. 1989 Nov-Dec; 30(6):505-11.
Valproic acid for dysphoric mania in a mentally retarded adolescent. [J Clin Psychiatry. 1995]
Valproic acid for dysphoric mania in a mentally retarded adolescent.
Whittier MC, West SA, Galli VB, Raute NJ. J Clin Psychiatry. 1995 Dec; 56(12):590-1.
Review Clinical pharmacology of aggressive behavior. [Clin Neuropharmacol. 1984]
Review Clinical pharmacology of aggressive behavior.
Sheard MH. Clin Neuropharmacol. 1984; 7(3):173-83.
Review Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system. [Prog Neurobiol. 1990]
Review Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system.
Cotariu D, Zaidman JL, Evans S. Prog Neurobiol. 1990; 34(4):343-54.

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. [Neuropsychopharmacology. 2010]
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.
Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E. Neuropsychopharmacology. 2010 Mar; 35(4):990-8. Epub 2009 Dec 9.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Valproic acid for nonaffective aggression in the mentally retarded.
Valproic acid for nonaffective aggression in the mentally retarded.
J Nerv Ment Dis. 1992 Sep ;180(9):601-2.

PubMed
RIGging an antiviral defense--it's in the CARDs.
RIGging an antiviral defense--it's in the CARDs.
Nat Immunol. 2004 Jul ;5(7):699-701.

PubMed
Post-proteasomal antigen processing for major histocompatibility complex class I...
Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Nat Immunol. 2004 Jul ;5(7):670-7.

PubMed
Prevalence estimates of substance abuse in schizophrenia and their correlates.
Prevalence estimates of substance abuse in schizophrenia and their correlates.
J Nerv Ment Dis. 1992 Sep ;180(9):589-92; discussion 593-6.

PubMed
Survey of the needs of patients with spinal cord injury: impact and priority for...
Survey of the needs of patients with spinal cord injury: impact and priority for improvement in hand function in tetraplegics.
Spinal Cord. 2004 Sep ;42(9):526-32.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed